|
WRN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.017600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.272060E-02 |
| Normal-vs-Stage2 |
8.179400E-01 |
| Normal-vs-Stage3 |
1.92378999999132E-05 |
| Normal-vs-Stage4 |
2.354300E-04 |
| Stage1-vs-Stage2 |
2.621400E-01 |
| Stage1-vs-Stage3 |
1.863420E-03 |
| Stage1-vs-Stage4 |
1.687570E-02 |
| Stage2-vs-Stage3 |
1.799750E-02 |
| Stage2-vs-Stage4 |
3.062300E-02 |
| Stage3-vs-Stage4 |
7.724800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.823220E-03 |
| Normal-vs-AfricanAmerican |
7.583600E-02 |
| Normal-vs-Asian |
5.496000E-01 |
| Caucasian-vs-AfricanAmerican |
5.815800E-01 |
| Caucasian-vs-Asian |
6.104200E-01 |
| AfricanAmerican-vs-Asian |
7.814000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.497570E-03 |
| Normal-vs-Female |
1.380090E-02 |
| Male-vs-Female |
4.331600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.949400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.513900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.186470E-04 |
| Normal-vs-Age(81-100Yrs) |
7.500200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.334800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.155000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.697840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.630400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.523580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.054000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.183400E-01 |
| Normal-vs-Grade 2 |
9.337500E-02 |
| Normal-vs-Grade 3 |
7.83730000000205E-05 |
| Normal-vs-Grade 4 |
1.354040E-04 |
| Grade 1-vs-Grade 2 |
4.659400E-01 |
| Grade 1-vs-Grade 3 |
1.846420E-02 |
| Grade 1-vs-Grade 4 |
2.423700E-02 |
| Grade 2-vs-Grade 3 |
1.257160E-03 |
| Grade 2-vs-Grade 4 |
7.164700E-03 |
| Grade 3-vs-Grade 4 |
4.511200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.292020E-02 |
| Normal-vs-ccB subtype |
5.597900E-02 |
| ccA subtype-vs-ccB subtype |
7.832000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.276210E-02 |
| Normal-vs-N1 |
9.715500E-02 |
| N0-vs-N1 |
6.563800E-01 |
|
|
